Organometallic Compounds, Vol. 1, Part 2 (Aylett, B. J.)

Cover Vol.1, No.2

cover Vol. 2 No. 1

Cruciaromaticity in organometallic compounds

A recent suggestion, that transition metal complexes of unsaturated ligands can be regarded as cruciconjugated, is explored by studies of various complexes of Fe(II), the aromaticity of the resulting i systems being analyzed in terms of PMO theory. This approach is also applied to porphyrin. The conclusions are supported by preliminary SCF and MNDO calculations.

Organometallic Anticancer Compounds

Gilles Gasser,* Ingo Ott,* and Nils Metzler-Nolte* Institute of Inorganic Chemistry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland, Institute of Pharmaceutical Chemistry, Technische Universit€ at Braunschweig, Beethovenstrasse 55, 38106 Braunschweig, Germany, and Chair of Inorganic Chemistry I, Bioinorganic Chemistry, Faculty of Chemistry and Biochemistry, Ruhr Univ...

Therapeutic Organometallic Compounds

Most drugs used today are purely organic compounds. Especially after the enormous success of the cisplatin (Fig 1) in tumor treatment, interest in metal complexes has grown (Allardyce & Dyson, 2006). Synthetic organometallic compounds are generally considered to be toxic or non-compatible with biological systems. Despite this perception, the medicinal properties of organometallic compounds, in ...